What is it about?
Diabetes is a growing health issue in India, particularly in Maharashtra and Karnataka. Artificial Intelligence (AI) has the potential to improve diabetes care by helping doctors diagnose the disease early, customize treatments, and monitor patients more effectively. However, AI adoption remains limited outside major cities due to challenges like lack of awareness, infrastructure gaps, and concerns about data privacy. Key Takeaways: AI can improve early detection, personalize treatments, and support continuous patient monitoring. Many healthcare professionals are unfamiliar with AI, requiring better training programs. Government policies should address AI regulations, data security, and healthcare accessibility. AI developers must design user-friendly tools that build patient trust and engagement. By overcoming these barriers, AI can revolutionize diabetes care, making healthcare more accessible and efficient for all.
Featured Image
Photo by Towfiqu barbhuiya on Unsplash
Why is it important?
This study is important because it addresses a critical healthcare gap in India: bridging the "quality divide" between metropolitan and non-metropolitan diabetes care. While India is often called the "Diabetes Capital of the World," advanced care is heavily concentrated in major cities. This research highlights how AI can democratize access to life-saving management for millions living outside these hubs. Key reasons why this matters: Tackling the "Silent Epidemic": In non-metropolitan areas, diabetes often goes undiagnosed until severe complications arise. This study shows how AI can enable mass screening and early risk assessment without needing immediate specialist intervention. Overcoming Specialist Shortages: With a severe scarcity of endocrinologists in Tier-2 and Tier-3 cities, the study demonstrates how AI tools can act as "force multipliers," allowing general practitioners to offer personalized, specialist-level treatment plans. Moving from "Sick Care" to "Health Care": By focusing on behavioral change and continuous monitoring, the findings suggest AI can shift the system from merely treating complications to proactively managing lifestyle—crucial for a chronic condition like diabetes. Roadmap for Scale: Unlike theoretical papers, this study offers practical "ground truths" from 15 specific hospitals, providing a realistic blueprint for policymakers to scale digital health solutions in resource-constrained settings (e.g., addressing literacy and infrastructure first). In short: It moves the conversation from "AI is futuristic" to "AI is a practical necessity" for equitable healthcare in India.
Perspectives
A Bridge, Not Just a Bot: Why Rural AI Matters More Than Metro Tech Living in the age of "AI everywhere," it is easy to get cynical about the hype. We often hear about AI writing code or generating art, but this study on diabetes care in Maharashtra and Karnataka hits differently. It reminds us that the true potential of AI isn’t just about efficiency—it’s about equity. What strikes me most about these findings is the stark reality of the "geography lottery." In India, if you develop diabetes in a metropolitan hub like Bengaluru or Mumbai, you have access to world-class endocrinologists and continuous glucose monitors. But drive just four hours out of the city, and that support structure often vanishes. The "Super-Generalist" Effect This research suggests that AI can act as the great equalizer. It doesn't replace the rural doctor; it upgrades them. By handling the heavy lifting of data analysis—predicting risks, flagging anomalies, and suggesting lifestyle tweaks—AI empowers a general physician in a non-metro clinic to offer care comparable to a super-specialist. It turns a standard check-up into a precision medicine intervention. The Human Hurdles However, the study also offers a necessary reality check. We can drop the most advanced algorithms into these hospitals, but they won't work if the infrastructure is shaky or if the doctors themselves don't trust the "black box" telling them what to do. The finding that AI literacy is a major barrier is crucial. We cannot just build the tool; we have to teach the craft. The Bottom Line For me, the most exciting takeaway isn't the technology itself, but the shift in focus from "treating sickness" to "managing health." Diabetes is a behavioral disease as much as a biological one. If AI can nudge a patient in rural Karnataka to change their diet or adhere to medication before they end up in the emergency room, that is not just technological progress—that is a fundamental humanitarian win. This study proves that the most impactful AI won't be the flashiest; it will be the one that quietly runs in the background of a clinic in a small town, saving lives by bridging the gap between access and expertise.
Mrinmoy Roy
Lovely Professional University
Read the Original
This page is a summary of: Adoption of AI-based diabetes diagnosis: a patient and institutional perspective in Maharashtra and Karnataka, International Journal of Pharmaceutical and Healthcare Marketing, November 2025, Emerald,
DOI: 10.1108/ijphm-10-2024-0111.
You can read the full text:
Contributors
The following have contributed to this page
